Oncology Fellowship

Gynecologic Oncology Fellowship Program Directors

 

On behalf of the University of Chicago and NorthShore, Dr. Nita Lee (Fellowship Program Director) and Dr.  Elena Diaz Moore (Assistant Program Director) are excited to introduce you to our program. We are committed to training outstanding clinician-scientists who will be the future leaders in the field of gynecologic oncology. Our program was initially approved in 2010 and is a 3-year curriculum consisting of 12 months of protected research time and 24 months of alternating clinical rotations at our 2 campuses (block diagram schedule below). We are proud of the comradery and collaboration among faculty members and fellows and believe this is palpable to all who visit.

Our gynecologic oncology programs continue to expand at both campuses. Currently, we have 11 faculty members who have trained at 9 different institutions, accompanied by diversity and breadth of clinical practice patterns and expertise. Both campuses offer robust surgical volume, including a busy robotics program, as well as a large number of upper abdominal tumor debulking and other radical pelvic surgery cases. We have dedicated research laboratories within the Sections of Gynecologic Oncology at both institutions, strong collaborations with clinical researchers resulting in a breadth of research opportunities for our trainees, a fierce commitment to clinical trials and clinical trial development, and a diverse patient population with a full spectrum of disease. 

The goals of our program are to train:

  1. Excellent surgeons, independently competent in the breadth of complex surgical procedures a gynecologic oncologist should be able to perform, including open, laparoscopic, robotic, and vaginal surgery.
  2. Outstanding clinicians with an expansive knowledge of tumor biology, the principles of gynecologic malignancies, treatment, and associated medical conditions.
  3. Oncologists with a strong understanding of chemotherapy drugs, including standard cytotoxic chemotherapy and targeted and experimental agents, accompanied by an understanding of the indications, mechanisms, administration, expected response and toxicity of such agents
  4. Physicians competent in the principles of palliative care and able to communicate effectively with their patients about goals of care and end of life issues.
  5. Compassionate providers who can recognize patients as people, put patients’ needs ahead of their own, exercise ethical practice, and utilize systems-based learning to continue to improve the care of patients and move the field of gynecologic oncology further ahead.
  6. Gynecologic oncology educators, committed to training the next generation of gynecologic oncologists, expanding the knowledge of their staff and allied health professionals, and providing their patients with an understanding of their disease and health related conditions.
  7. Oncologists with high regard for research, either evident in their own academic careers as clinician-scientists, or shown by an appreciation for and understanding of ongoing investigations, that encompasses the critical interpretation of the literature and the judicious application of research findings to patient care.

 

3-year fellowship
2 month lead in clinical rotation
12 dedicated research months
22 total gynecologic oncology clinical months
2 off-service rotations
--SICU
--Phase 1 clinic/palliative care 

Year

Jul

Aug

Sep

Oct

Nov

Dec

Jan

Feb

Mar

Apr

May

Jun

1

NS

UC

RES

RES

RES

RES

RES

RES

RES

RES

RES

RES

2

RES

RES

UC

UC

UC

NS

NS

SICU

NS

NS

UC

UC

3

UC

NS

NS

NS

NS

UC

UC

UC

UC

Phase 1 Palliative

NS

NS

 

UC=University of Chicago Medical Center
NS=NorthShore University Medical System
Res=Research
Phase I/Palliative Care
SICU=Surgery ICU

 

Best Wishes,

Nita Karnik Lee, MD, MPH

Program Director

Elena Diaz Moore, MD

Assistant Program Director